You have 9 free searches left this month | for more free features.

pf-03084014

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)

Active, not recruiting
  • Desmoid Tumors
  • Aggressive Fibromatosis
  • PF-03084014
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2022

Tumors by Histologic Type Trial in Italy, United States (PF-03084014)

Completed
  • Neoplasms by Histologic Type
  • PF-03084014
  • Aurora, Colorado
  • +9 more
Oct 21, 2019

Breast Cancer Metastatic Trial in Worldwide (PF-03084014, Docetaxel)

Terminated
  • Breast Cancer Metastatic
  • Birmingham, Alabama
  • +15 more
Mar 14, 2019

Tumor, Desmoid Tumor Trial in Aurora (PF-03084014)

No longer available
  • Neoplasm
  • Desmoid Tumor
  • PF-03084014
  • Aurora, Colorado
    University of Colorado
Jan 30, 2019

Metastatic Cancer Pancreas Trial in Aurora, Rochester (PF-03084014, Gemcitabine, Nab-paclitaxel)

Terminated
  • Metastatic Cancer Pancreas
  • PF-03084014
  • +2 more
  • Aurora, Colorado
  • +4 more
Dec 20, 2018

Triple Negative Breast Tumors Trial in Worldwide (PF-03084014)

Terminated
  • Triple Negative Breast Neoplasms
  • PF-03084014
  • Stanford, California
  • +36 more
Dec 19, 2018

Breast Cancer Trial in Belgium, France (PF-03084014, Breast cancer surgery)

Withdrawn
  • Breast Cancer
  • PF-03084014
  • Breast cancer surgery
  • Brussels, Belgium
  • +4 more
Apr 28, 2016

Advanced Solid Tumors Trial (PF-03084014)

Withdrawn
  • Advanced Solid Tumors
  • PF-03084014
  • (no location specified)
Oct 6, 2015